** = Publications listed in SCI/SSCI/Pubmed
** Nayak, BB; Bärnthaler, T; Rajesh, R; Teppan, J; Gogg, T; Douschan, P; Kneidinger, N; van, der, Does, AM; Hiemstra, P; Heinemann, A; Böhm, E
Brepocitinib, a selective TYK2/JAK1 inhibitor, mitigates neutrophilic inflammation and glucocorticoid receptor-β expression in COPD.
Am J Physiol Lung Cell Mol Physiol. 2026;
Doi: 10.1152/ajplung.00237.2025
PubMed
FullText
FullText_MUG